Segment Reporting (Tables)

6 Months Ended

Jun. 30, 2026

Segment Reporting [Abstract]

Schedule of Operating Financial Results of Reportable Segment

The following table provides the operating financial results of the Company’s single reportable segment. It includes the significant expense categories regularly provided to the Company’s "chief operating decision maker", its Chief Executive Officer, computed under GAAP and reconciled to the Company’s total “net loss” as presented in the Condensed Statements of Operations and Comprehensive Loss:


		Three Months Ended June 30,								Six Months Ended June 30,
(in thousands)		2026				2025				2026				2025
Revenue		$	18,940			$	12,083			$	35,056			$	22,272

Less:
Cost of sales			4,398				3,214				8,089				5,767
Selling expenses			9,157				6,028				17,042				11,042
Marketing expenses			1,173				840				2,663				1,772
Product and software development costs			3,576				2,171				6,652				3,651
Clinical, medical, and regulatory expenses			1,358				1,167				2,705				2,188
Other segment expenses*			10,314				5,165				18,217				10,073
Interest expense			313				363				624				720
Interest income			(839	)			(336	)			(1,730	)			(716	)
Change in fair value of warrant liabilities			—				237				—				270
Net loss		$	(10,510	)		$	(6,766	)		$	(19,206	)		$	(12,495	)

* Other segment expenses primarily include corporate, compliance, and research and development support expenses.